AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. ELAN
  4. [Form 4] Elanco Animal Health Incorporated Insider Trading Activity

[Form 4] Elanco Animal Health Incorporated Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

First Busey Corp. (BUSE) 鈥� Form 4: Director Frederic L. Kenney reported one insider transaction dated 07/25/2025.

  • Security: Common stock.
  • Transaction type/code: 鈥淎鈥� (automatic acquisition).
  • Shares acquired: 294, stemming from dividend-equivalent rights credited on Deferred Stock Units; reported price $0.
  • Post-transaction beneficial ownership: 31,879 shares held directly (D); 16,349 shares held indirectly (I) through spouse.

No shares were disposed of and no derivative securities were listed. The filing reflects routine dividend accrual rather than an open-market purchase.

First Busey Corp. (BUSE) 鈥� Modulo 4: Il direttore Frederic L. Kenney ha riportato una transazione interna datata 25/07/2025.

  • Titolo: Azioni ordinarie.
  • Tipo/codice transazione: 鈥淎鈥� (acquisizione automatica).
  • Azioni acquisite: 294, derivanti da diritti equivalenti ai dividendi accreditati su Unit脿 Azionarie Differite; prezzo riportato $0.
  • Detenzione beneficiaria post-transazione: 31.879 azioni detenute direttamente (D); 16.349 azioni detenute indirettamente (I) tramite il coniuge.

Non sono state cedute azioni n茅 elencati titoli derivati. La comunicazione riflette un accantonamento di dividendi di routine e non un acquisto sul mercato aperto.

First Busey Corp. (BUSE) 鈥� Formulario 4: El director Frederic L. Kenney report贸 una transacci贸n interna fechada el 25/07/2025.

  • Valor: Acciones comunes.
  • Tipo/c贸digo de transacci贸n: 鈥淎鈥� (adquisici贸n autom谩tica).
  • Acciones adquiridas: 294, derivadas de derechos equivalentes a dividendos acreditados en Unidades de Acciones Diferidas; precio reportado $0.
  • Propiedad beneficiaria post-transacci贸n: 31,879 acciones en propiedad directa (D); 16,349 acciones en propiedad indirecta (I) a trav茅s del c贸nyuge.

No se dispusieron acciones ni se listaron valores derivados. El reporte refleja una acumulaci贸n rutinaria de dividendos y no una compra en el mercado abierto.

韻检姢韸� 攵�鞁� 旖旐嵓霠堨澊靺� (BUSE) 鈥� 鞏戩嫕 4: 鞚挫偓 頂勲爤雿半Ν L. 旒�雼堦皜 2025雲� 7鞗� 25鞚检瀽 雮措秬鞛� 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟.

  • 歃濌秾: 氤错喌欤�.
  • 瓯半灅 鞙犿槙/旖旊摐: 鈥淎鈥� (鞛愲彊 旆摑).
  • 旆摑 欤检嫕 靾�: 294欤�, 鞚挫棸 欤检嫕 雼渼鞐� 鞝侂霅� 氚半嫻旮� 靸侂嫻 甓岆Μ鞐愳劀 氚滌儩; 氤搓碃霅� 臧�瓴� $0.
  • 瓯半灅 頉� 鞁れ 靻岇湢甓�: 歆侅爲 氤挫湢 (D) 31,879欤�; 氚办毎鞛愲ゼ 韱淀暅 臧勳爲 氤挫湢 (I) 16,349欤�.

欤检嫕 觳橂秳鞚措倶 韺岇儩 歃濌秾鞚� 鞐嗢棃鞙茧┌, 鞚措矆 氤搓碃電� 瓿店皽 鞁滌灔鞐愳劀鞚� 毵れ垬臧� 鞎勲媽 鞝曣赴 氚半嫻 鞝侂鞚� 氚橃榿頃╇媹雼�.

First Busey Corp. (BUSE) 鈥� Formulaire 4 : Le directeur Frederic L. Kenney a d茅clar茅 une transaction d鈥檌niti茅 dat茅e du 25/07/2025.

  • Titre : Actions ordinaires.
  • Type/code de transaction : 芦 A 禄 (acquisition automatique).
  • Actions acquises : 294, r茅sultant de droits 茅quivalents aux dividendes cr茅dit茅s sur des unit茅s d鈥檃ctions diff茅r茅es ; prix d茅clar茅 0 $.
  • Propri茅t茅 b茅n茅ficiaire apr猫s transaction : 31 879 actions d茅tenues directement (D) ; 16 349 actions d茅tenues indirectement (I) via le conjoint.

Aucune action n鈥檃 茅t茅 c茅d茅e et aucun titre d茅riv茅 n鈥檃 茅t茅 list茅. Le d茅p么t refl猫te un simple cumul de dividendes et non un achat sur le march茅 ouvert.

First Busey Corp. (BUSE) 鈥� Formular 4: Direktor Frederic L. Kenney meldete eine Insider-Transaktion vom 25.07.2025.

  • Sicherheit: Stammaktien.
  • Transaktionstyp/-code: 鈥濧鈥� (automatischer Erwerb).
  • Erworbene Aktien: 294, resultierend aus dividenden盲quivalenten Rechten, gutgeschrieben auf aufgeschobene Aktienanteile; gemeldeter Preis $0.
  • Nach der Transaktion wirtschaftliches Eigentum: 31.879 Aktien direkt gehalten (D); 16.349 Aktien indirekt gehalten (I) 眉ber den Ehepartner.

Es wurden keine Aktien ver盲u脽ert und keine Derivate gelistet. Die Meldung spiegelt eine routinem盲脽ige Dividendenanrechnung wider und keinen Kauf am offenen Markt.

Positive
  • Director ownership increases by 294 shares, bringing direct holdings to 31,879 shares, indicating continued alignment with shareholders.
Negative
  • None.

Insights

TL;DR: Small, routine dividend-equivalent accrual; negligible market impact.

The 294-share credit represents less than 1% of Mr. Kenney鈥檚 total reported holdings and was executed at $0 under the company鈥檚 deferred stock unit program, not via open market. Such administrative accruals are customary and do not signal a change in insider sentiment. Total direct ownership now stands at 31,879 shares, with an additional 16,349 shares held indirectly through his spouse. Given the modest size and non-cash nature of the transaction, I view the filing as informational with neutral impact on valuation.

First Busey Corp. (BUSE) 鈥� Modulo 4: Il direttore Frederic L. Kenney ha riportato una transazione interna datata 25/07/2025.

  • Titolo: Azioni ordinarie.
  • Tipo/codice transazione: 鈥淎鈥� (acquisizione automatica).
  • Azioni acquisite: 294, derivanti da diritti equivalenti ai dividendi accreditati su Unit脿 Azionarie Differite; prezzo riportato $0.
  • Detenzione beneficiaria post-transazione: 31.879 azioni detenute direttamente (D); 16.349 azioni detenute indirettamente (I) tramite il coniuge.

Non sono state cedute azioni n茅 elencati titoli derivati. La comunicazione riflette un accantonamento di dividendi di routine e non un acquisto sul mercato aperto.

First Busey Corp. (BUSE) 鈥� Formulario 4: El director Frederic L. Kenney report贸 una transacci贸n interna fechada el 25/07/2025.

  • Valor: Acciones comunes.
  • Tipo/c贸digo de transacci贸n: 鈥淎鈥� (adquisici贸n autom谩tica).
  • Acciones adquiridas: 294, derivadas de derechos equivalentes a dividendos acreditados en Unidades de Acciones Diferidas; precio reportado $0.
  • Propiedad beneficiaria post-transacci贸n: 31,879 acciones en propiedad directa (D); 16,349 acciones en propiedad indirecta (I) a trav茅s del c贸nyuge.

No se dispusieron acciones ni se listaron valores derivados. El reporte refleja una acumulaci贸n rutinaria de dividendos y no una compra en el mercado abierto.

韻检姢韸� 攵�鞁� 旖旐嵓霠堨澊靺� (BUSE) 鈥� 鞏戩嫕 4: 鞚挫偓 頂勲爤雿半Ν L. 旒�雼堦皜 2025雲� 7鞗� 25鞚检瀽 雮措秬鞛� 瓯半灅毳� 氤搓碃頄堨姷雼堧嫟.

  • 歃濌秾: 氤错喌欤�.
  • 瓯半灅 鞙犿槙/旖旊摐: 鈥淎鈥� (鞛愲彊 旆摑).
  • 旆摑 欤检嫕 靾�: 294欤�, 鞚挫棸 欤检嫕 雼渼鞐� 鞝侂霅� 氚半嫻旮� 靸侂嫻 甓岆Μ鞐愳劀 氚滌儩; 氤搓碃霅� 臧�瓴� $0.
  • 瓯半灅 頉� 鞁れ 靻岇湢甓�: 歆侅爲 氤挫湢 (D) 31,879欤�; 氚办毎鞛愲ゼ 韱淀暅 臧勳爲 氤挫湢 (I) 16,349欤�.

欤检嫕 觳橂秳鞚措倶 韺岇儩 歃濌秾鞚� 鞐嗢棃鞙茧┌, 鞚措矆 氤搓碃電� 瓿店皽 鞁滌灔鞐愳劀鞚� 毵れ垬臧� 鞎勲媽 鞝曣赴 氚半嫻 鞝侂鞚� 氚橃榿頃╇媹雼�.

First Busey Corp. (BUSE) 鈥� Formulaire 4 : Le directeur Frederic L. Kenney a d茅clar茅 une transaction d鈥檌niti茅 dat茅e du 25/07/2025.

  • Titre : Actions ordinaires.
  • Type/code de transaction : 芦 A 禄 (acquisition automatique).
  • Actions acquises : 294, r茅sultant de droits 茅quivalents aux dividendes cr茅dit茅s sur des unit茅s d鈥檃ctions diff茅r茅es ; prix d茅clar茅 0 $.
  • Propri茅t茅 b茅n茅ficiaire apr猫s transaction : 31 879 actions d茅tenues directement (D) ; 16 349 actions d茅tenues indirectement (I) via le conjoint.

Aucune action n鈥檃 茅t茅 c茅d茅e et aucun titre d茅riv茅 n鈥檃 茅t茅 list茅. Le d茅p么t refl猫te un simple cumul de dividendes et non un achat sur le march茅 ouvert.

First Busey Corp. (BUSE) 鈥� Formular 4: Direktor Frederic L. Kenney meldete eine Insider-Transaktion vom 25.07.2025.

  • Sicherheit: Stammaktien.
  • Transaktionstyp/-code: 鈥濧鈥� (automatischer Erwerb).
  • Erworbene Aktien: 294, resultierend aus dividenden盲quivalenten Rechten, gutgeschrieben auf aufgeschobene Aktienanteile; gemeldeter Preis $0.
  • Nach der Transaktion wirtschaftliches Eigentum: 31.879 Aktien direkt gehalten (D); 16.349 Aktien indirekt gehalten (I) 眉ber den Ehepartner.

Es wurden keine Aktien ver盲u脽ert und keine Derivate gelistet. Die Meldung spiegelt eine routinem盲脽ige Dividendenanrechnung wider und keinen Kauf am offenen Markt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Modi Rajeev A.
(Last) (First) (Middle)
C/O ELANCO ANIMAL HEALTH INCORPORATED
2500 INNOVATION WAY
(Street)
GREENFIELD IN 46140
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SEE REMARKS
3. Date of Earliest Transaction (Month/Day/Year)
07/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Stock Units (1) 07/25/2025 A 94.8137 (2) (2) Common Stock 94.8137 $14.92 6,650.4449 D
Explanation of Responses:
1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Remarks:
Executive Vice President U.S. Pet Health and Global Digital Transformation
/s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi 07/29/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What type of insider transaction was reported for BUSE?

Director Frederic L. Kenney reported an automatic acquisition (code 鈥淎鈥�) of 294 common shares via dividend-equivalent rights.

How many First Busey (BUSE) shares does Kenney now own?

After the transaction, he holds 31,879 shares directly and 16,349 shares indirectly through his spouse.

Was the transaction an open-market purchase?

No. The shares were credited at $0 as part of dividend-equivalent rights attached to Deferred Stock Units, not bought on the open market.

Did the Form 4 report any share disposals or derivative trades?

No shares were disposed of and no derivative securities were reported in this filing.

What is the significance of dividend-equivalent rights in Form 4 filings?

Dividend-equivalent rights reflect automatic share credits equal to cash dividends on deferred units, increasing ownership without cash outlay.
Stock ELAN logo
Elanco Animal Health

NYSE:ELAN

ELAN Rankings

#1786 Ranked by Market Cap
N/A Ranked by Dividends

ELAN Latest News

Jul 24, 2025
Elanco Secures Approval of Zenrelia鈩� (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs
Jul 10, 2025
Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement
Jul 9, 2025
Elanco Receives USDA Approval for TruCan鈩� Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection
Jul 2, 2025
Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001
Jun 26, 2025
Elanco Releases 2024 Impact Report and Introduces New Framework

ELAN Latest SEC Filings

Jul 29, 2025
[Form 4] Elanco Animal Health Incorporated Insider Trading Activity
Jul 15, 2025
[Form 4] Elanco Animal Health Incorporated Insider Trading Activity
Jul 15, 2025
[Form 4] Elanco Animal Health Incorporated Insider Trading Activity
Jul 14, 2025
[Form 3] Elanco Animal Health Incorporated Initial Statement of Beneficial Ownership
Jul 8, 2025
[Form 4] Elanco Animal Health Incorporated Insider Trading Activity

ELAN Stock Data

7.01B
491.23M
0.88%
100.87%
2.92%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
United States
GREENFIELD